Clinical Trial Update: Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device [NA]

View source ↗

Summary

Clinical trial evaluating software enhancements to a respiratory device (BiPAP autoSV) versus BiPAP S/T; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep-disordered Breathing

Drugs mentioned

• BiPAP S/T (BiPAP S/T)
• BiPAP autoSV (BiPAP autoSV)

Snippet

Sponsor: Philips Respironics | Conditions: Sleep Disordered Breathing | NA | Status: TERMINATED | Results posted: 2019-04-09